[Report] Navigating the New Political Landscape at JPM 2025
With tech and other industries actively aligning with the incoming administration, how are healthcare companies navigating the evolving political landscape — and how did that show up at the J.P. Morgan Healthcare Conference (JPM)?
What did top companies say about the new administration? And how were presentations and panels reflected in media coverage and social conversations?
To look at the policy discussion at JPM 2025, our experts used Real Chemistry’s suite of social and media tracking tools alongside our proprietary AI and natural language processing (NLP) capabilities. They captured and analyzed:
-
More than 4,000 mentions of JPM across X and LinkedIn
-
907 relevant news articles
-
29 transcripts of live presentations from top pharma and biotech companies
Access insights across corporate pricing, public affairs, social listening, and investor relations by downloading our JPM 2025 Report using the form below.
Download the Report
As online and media conversations around health policy and the new administration continue to evolve, staying abreast of peers’ messaging and healthcare stakeholders’ changing expectations of companies will be more critical than ever. Contact Meredith Owen at I2marketing@realchemistry.com to learn more about how our suite of Intelligence tools can help you anticipate and predict where the conversation is headed.
For more Real Chemistry insights on biopharma industry policies, politics, and pricing news, subscribe to our free weekly Value Report, delivered to your inbox every Friday.
